Design Therapeutics

Design Therapeutics is one of the...

• Russell 3000.

Design Therapeutics is a company listed under the stock ticker DSGN (US).

View the org chart displaying its 13 main executives

Most searched biographies at Design Therapeutics

• Pratik Shah, Executive Chairman of the Board and Chief Executive O...
• Heather Behanna, Director
• Deepa Prasad, Director

Popular executive movements at Design Therapeutics

• João Siffert, Chief Executive Officer and Director, has left the company  (posted on August 28 2023).
• Pratik Shah who is Executive Chairman, will be promoted to Executive Chairman of the Board and Chief Executive Officer on Sep. 1, 2023  (posted on August 28 2023).

Create your alert
to follow the executive moves at Design Therapeutics.

Design Therapeutics has 2,294 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Design Therapeutics

Social media about Design Therapeutics

• Design Therapeutics on Wikipedia, Google News & Yahoo Finance
• Design Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Heather Behanna

Call Design Therapeutics at +1 858...

View the org chart

Register to receive your alert

Report an error